Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Lodise

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Antimicrobial Chemotherapy|August 13, 2008
Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemiaT P Lodise, C D Miller, J Graves, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2009
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureusN Patel, P Lubanski, S Ferro, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 2017
Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot studyD M Martirosov, M R Bidell, M P Pai, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targetsG L Drusano, T P Lodise, D Melnick, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapyT W Felton, J A Roberts, T P Lodise, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infectionsT W Felton, W W Hope, B M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial AgentsM L Rizk, S M Bhavnani, G Drusano, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2014
Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin T P Lodise, G L Drusano, V Lazariu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Antimicrobial Chemotherapy|August 13, 2008
Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemiaT P Lodise, C D Miller, J Graves, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2009
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureusN Patel, P Lubanski, S Ferro, et al.
Diagnostic Microbiology and Infectious Disease|April 29, 2017
Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5mg/L: A pilot studyD M Martirosov, M R Bidell, M P Pai, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targetsG L Drusano, T P Lodise, D Melnick, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapyT W Felton, J A Roberts, T P Lodise, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infectionsT W Felton, W W Hope, B M Lomaestro, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial AgentsM L Rizk, S M Bhavnani, G Drusano, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2014
Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin T P Lodise, G L Drusano, V Lazariu, et al.
Pageof 2